These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 22069522)
1. The hepatitis C virus glycan shield and evasion of the humoral immune response. Helle F; Duverlie G; Dubuisson J Viruses; 2011 Oct; 3(10):1909-32. PubMed ID: 22069522 [TBL] [Abstract][Full Text] [Related]
2. Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies. Lavie M; Hanoulle X; Dubuisson J Front Immunol; 2018; 9():910. PubMed ID: 29755477 [TBL] [Abstract][Full Text] [Related]
3. Antigenicity and Immunogenicity of Differentially Glycosylated Hepatitis C Virus E2 Envelope Proteins Expressed in Mammalian and Insect Cells. Urbanowicz RA; Wang R; Schiel JE; Keck ZY; Kerzic MC; Lau P; Rangarajan S; Garagusi KJ; Tan L; Guest JD; Ball JK; Pierce BG; Mariuzza RA; Foung SKH; Fuerst TR J Virol; 2019 Apr; 93(7):. PubMed ID: 30651366 [TBL] [Abstract][Full Text] [Related]
4. Role of the E2 Hypervariable Region (HVR1) in the Immunogenicity of a Recombinant Hepatitis C Virus Vaccine. Law JLM; Logan M; Wong J; Kundu J; Hockman D; Landi A; Chen C; Crawford K; Wininger M; Johnson J; Mesa Prince C; Dudek E; Mehta N; Tyrrell DL; Houghton M J Virol; 2018 Jun; 92(11):. PubMed ID: 29540595 [TBL] [Abstract][Full Text] [Related]
5. Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody. Li Y; Pierce BG; Wang Q; Keck ZY; Fuerst TR; Foung SK; Mariuzza RA J Biol Chem; 2015 Apr; 290(16):10117-25. PubMed ID: 25737449 [TBL] [Abstract][Full Text] [Related]
8. A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1. Johnson J; Freedman H; Logan M; Wong JAJ; Hockman D; Chen C; He J; Beard MR; Eyre NS; Baumert TF; Tyrrell DL; Law JLM; Houghton M J Virol; 2019 Nov; 93(22):. PubMed ID: 31462563 [TBL] [Abstract][Full Text] [Related]
9. Glycan shifting on hepatitis C virus (HCV) E2 glycoprotein is a mechanism for escape from broadly neutralizing antibodies. Pantua H; Diao J; Ultsch M; Hazen M; Mathieu M; McCutcheon K; Takeda K; Date S; Cheung TK; Phung Q; Hass P; Arnott D; Hongo JA; Matthews DJ; Brown A; Patel AH; Kelley RF; Eigenbrot C; Kapadia SB J Mol Biol; 2013 Jun; 425(11):1899-1914. PubMed ID: 23458406 [TBL] [Abstract][Full Text] [Related]